The team employed cycloserine, a drug already approved for use by - TopicsExpress



          

The team employed cycloserine, a drug already approved for use by the FDA, which is known to assist NMDA receptor function. This boost of NMDA receptor function was able to restore synaptic firing and thereby restore network activity in the animal model. The restoration of normal network activity reversed the behavioral abnormalities seen in the mice. medicalxpress/news/2014-12-potential-therapy-common-dementia.html HEALTH Portation curated News
Posted on: Fri, 05 Dec 2014 16:08:16 +0000

Trending Topics



Recently Viewed Topics




© 2015